Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $80.50 USD
Change Today -0.31 / -0.38%
Volume 1.1M
TROW On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 1:58 PM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

t rowe price group inc (TROW) Snapshot

Open
$80.41
Previous Close
$80.81
Day High
$80.61
Day Low
$79.82
52 Week High
12/30/14 - $86.48
52 Week Low
10/15/14 - $70.03
Market Cap
21.0B
Average Volume 10 Days
1.0M
EPS TTM
$4.53
Shares Outstanding
260.6M
EX-Date
06/11/15
P/E TM
17.8x
Dividend
$2.08
Dividend Yield
4.77%
Current Stock Chart for T ROWE PRICE GROUP INC (TROW)

t rowe price group inc (TROW) Details

T. Rowe Price Group, Inc. is a publicly owned asset management holding company. The firm provides its services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions. It invests in the public equity and fixed income markets across the globe. It also invests in alternative markets, including currency markets. The firm employs fundamental and quantitative analysis with a bottom-up approach. It utilizes in-house and external research to make its investments. The firm employs socially responsible investing with a focus on environmental, social, and governance issues. It was previously known as T. Rowe Group, Inc. and T. Rowe Price Associates, Inc. T. Rowe Price Group, Inc. was founded in 1937 and is based in Baltimore, Maryland with additional offices in Colorado Springs, Colorado, Owings Mills, Maryland, San Francisco, California, Los Angeles, California, Tampa, Florida, Toronto, Ontario, Hellerup, Denmark, Amsterdam, The Netherlands, Luxembourg, Grand Duchy of Luxembourg, Zurich, Switzerland, Dubai, United Arab Emirates, London, United Kingdom, Sydney, New South Wales, Hong Kong, Tokyo, Japan, and Singapore.

5,905 Employees
Last Reported Date: 04/22/15
Founded in 1937

t rowe price group inc (TROW) Top Compensated Officers

Chief Executive Officer, President, Director,...
Total Annual Compensation: $350.0K
Chairman, Chief Investment Officer, Vice Pres...
Total Annual Compensation: $350.0K
Chief Financial Officer, Vice President, and ...
Total Annual Compensation: $350.0K
Vice Chairman, Vice President, Member of Mana...
Total Annual Compensation: $350.0K
Head of Global Equity & Global Equity Researc...
Total Annual Compensation: $350.0K
Compensation as of Fiscal Year 2014.

t rowe price group inc (TROW) Key Developments

T. Rowe Price Closes Health Sciences Fund to New Investors

T. Rowe Price announced that it closed its Health Sciences Fund and similar portfolios for institutional clients at 4 p.m. ET on June 1, 2015. The decision to close the fund was made to maintain the integrity of the fund's investment strategy and to protect the interests of existing shareholders. While the fund is closed to new investors, it will continue to accept additional investments from existing shareholders and from participants in an employer-sponsored retirement plan for which the fund serves as an investment option. New IRAs may also be opened through a direct rollover from an employer-sponsored retirement plan. T. Rowe Price Health Sciences Fund, which launched on December 29, 1995, seeks long-term capital appreciation from the stocks of companies involved in health care, medicine, and life sciences. It has been managed since February 15, 2013, by Taymour Tamaddon, who has been an investment professional at T. Rowe Price since 2004. The Health Sciences Fund received an Overall Morningstar RatingTM of five stars as of April 30, 2015.1 Its ticker symbol is PRHSX. This is the first time the Health Sciences Fund has closed to new investors. The pace of inflows into the fund has increased dramatically in recent years. With $14.8 billion in total assets in the Health Sciences Strategy as of April 30, 2015–including $14.1 billion in the Health Sciences Fund–assets have risen by $5.9 billion since the end of 2013. The strategy had nearly $1.8 billion of inflows during that time, including $1.1 billion this year through April 30. Closing the fund to new investors will help ensure that additional inflows do not overwhelm the portfolio manager's ability to meet the fund's investment objective.

T. Rowe Price Group, Inc. Presents at Bank of America Merrill Lynch 2015 Emerging Markets Corporate Conference, May-27-2015 through May-29-2015

T. Rowe Price Group, Inc. Presents at Bank of America Merrill Lynch 2015 Emerging Markets Corporate Conference, May-27-2015 through May-29-2015. Venue: Fontainebleau Miami Beach, 4441 Collins Avenue, Miami Beach, Florida, United States. Presentation Date & Speakers: May-27-2015, Samy B. Muaddi, Vice President. May-28-2015, Samy B. Muaddi, Vice President.

T. Rowe Price Group Announces Management Changes

The Board of Directors of T. Rowe Price Group announced that James A.C. Kennedy, CEO and president and chair of the firm's Management Committee, has decided to step down from those roles, effective December 31, 2015. He will retire from the firm at the company's Annual Meeting on April 27, 2016. William J. Stromberg who is currently head of Global Equity and Global Equity Research and a member of the firm's Management Committee, will succeed Jim. Bill will become president and CEO and chair of the Management Committee, effective January 1, 2016. He will also join the Board of Directors at that time. As part of the transition, Eric L. Veiel, a director of Equity Research North America and a member of the U.S. Equity Steering Committee, will become head of U.S. Equity and chair of the U.S. Equity Steering Committee, effective January 1, 2016. He will also join the Management Committee at that time.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TROW:US $80.47 USD -0.34

TROW Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Invesco Ltd $39.76 USD -0.1099
KKR & Co LP $22.91 USD +0.04
Northern Trust Corp $74.40 USD +0.15
TD Ameritrade Holding Corp $37.46 USD +0.4975
Carlyle Group LP/The $29.41 USD -1.56
View Industry Companies
 

Industry Analysis

TROW

Industry Average

Valuation TROW Industry Range
Price/Earnings 17.7x
Price/Sales 5.1x
Price/Book 4.2x
Price/Cash Flow 15.6x
TEV/Sales 4.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact T ROWE PRICE GROUP INC, please visit www.troweprice.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.